GJIC
Gamble Jones Investment Counsel Portfolio holdings
AUM
$1.33B
This Quarter Return
-4.31%
1 Year Return
-11.55%
3 Year Return
+32.89%
5 Year Return
+72.78%
10 Year Return
–
AUM
$994M
AUM Growth
+$994M
(-8.1%)
Cap. Flow
-$22.7M
Cap. Flow
% of AUM
-2.28%
Top 10 Holdings %
Top 10 Hldgs %
46.94%
Holding
228
New
6
Increased
60
Reduced
99
Closed
19
Top Buys
| 1 |
Linde
LIN
|
$2.71M |
| 2 |
Workday
WDAY
|
$2.55M |
| 3 |
Vanguard High Dividend Yield ETF
VYM
|
$2.34M |
| 4 |
Charles Schwab
SCHW
|
$2.3M |
| 5 |
Meta Platforms (Facebook)
META
|
$2.15M |
Top Sells
| 1 |
Procter & Gamble
PG
|
$11.5M |
| 2 |
Willis Towers Watson
WTW
|
$4.8M |
| 3 |
iShares Short Treasury Bond ETF
SHV
|
$3.17M |
| 4 |
PX
Praxair Inc
PX
|
$2.83M |
| 5 |
JD.com
JD
|
$2.64M |
Sector Composition
| 1 | Consumer Staples | 32.66% |
| 2 | Technology | 13.4% |
| 3 | Healthcare | 11.17% |
| 4 | Financials | 8.83% |
| 5 | Industrials | 7.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Paychex
PAYX
$50.1B
| $755K | 0.08% |
11,586
-50
| -0.4% | -$3.26K |
|
127
Chubb
CB
$110B
| $731K | 0.07% |
5,662
-508
| -8% | -$65.6K |
|
128
Gilead Sciences
GILD
$140B
| $724K | 0.07% |
11,582
-4,060
| -26% | -$254K |
|
129
SPDR S&P MidCap 400 ETF Trust
MDY
$23.6B
| $717K | 0.07% |
2,370
+1,110
| +88% | +$336K |
|
130
Vanguard Dividend Appreciation ETF
VIG
$95B
| $713K | 0.07% |
7,274
-192
| -3% | -$18.8K |
|
131
Phillips 66
PSX
$54.1B
| $710K | 0.07% |
8,237
-754
| -8% | -$65K |
|
132
Zimmer Biomet
ZBH
$21B
| $686K | 0.07% |
6,615
-2,090
| -24% | -$217K |
|
133
Unilever
UL
$156B
| $679K | 0.07% |
12,995
-873
| -6% | -$45.6K |
|
134
Danaher
DHR
$147B
| $676K | 0.07% |
6,555
-75
| -1% | -$7.74K |
|
135
VanEck Biotech ETF
BBH
$352M
| $664K | 0.07% |
6,000
| – | – |
|
136
iShares Russell 2000 ETF
IWM
$66.6B
| $655K | 0.07% |
4,891
| – | – |
|
137
Nuveen California Quality Municipal Income Fund
NAC
$1.63B
| – | – |
0
| – | – |
|
138
iShares MSCI EAFE Small-Cap ETF
SCZ
$10.6B
| $636K | 0.06% |
12,275
+2,000
| +19% | +$104K |
|
139
GSK
GSK
$78.5B
| $627K | 0.06% |
16,408
-2,591
| -14% | -$99K |
|
140
Vanguard Small-Cap Value ETF
VBR
$31.2B
| $609K | 0.06% |
5,341
+67
| +1% | +$7.64K |
|
141
Aflac
AFL
$57.2B
| $606K | 0.06% |
13,307
| – | – |
|
142
iShares Core S&P Mid-Cap ETF
IJH
$99.6B
| $606K | 0.06% |
3,648
-45
| -1% | -$7.48K |
|
143
Hershey
HSY
$37.3B
| $600K | 0.06% |
5,600
| – | – |
|
144
Vanguard Intermediate-Term Bond ETF
BIV
$24B
| $594K | 0.06% |
7,312
| – | – |
|
145
Cigna
CI
$80.3B
| $586K | 0.06% |
3,085
+261
| +9% | +$49.6K |
|
146
Humana
HUM
$36.5B
| $573K | 0.06% |
2,000
| – | – |
|
147
Vanguard Small-Cap ETF
VB
$66.1B
| $565K | 0.06% |
4,284
+560
| +15% | +$73.9K |
|
148
Starbucks
SBUX
$102B
| $556K | 0.06% |
8,628
+129
| +2% | +$8.31K |
|
149
FedEx
FDX
$52.9B
| $552K | 0.06% |
3,423
-80
| -2% | -$12.9K |
|
150
Target
TGT
$42B
| $542K | 0.05% |
8,207
| – | – |
|